Posted On: 09/26/2013 7:10:53 AM
Post# of 72446
You guys follow Menon on Linkedin? He's updated his profile.
-
"Kevetrin" Indication Cancer in clinical trias
- June 2005 to Present
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
-
"Prurisol" for Psoriasis 505 (b)2
- January 2008 to Present
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
505 (b) (2)
-
KM-391 for Autism Spectrum Disorders
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
-
KM 12-82 Hematological Cancers
- April 2013 to Present
Team Members: Dr. Krishna Menon , Ashok Kumar, Siya Ram
-
Bilaricidin Phase 11 (b) clinical trials
- September 2013 to Present
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
New class antibiotics
-
Oral Mucisitis IND
- September 2013 to Present
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
-
Crohn's Disease
- September 2013 to Present
- Cellceutix, Inc.
Team Members: Dr. Krishna Menon
(0)
(0)
